Evidence map›Paper›PMID 33536291›Full record

ReviewJournal of clinical microbiology2021

Applications of Machine Learning to the Problem of Antimicrobial Resistance: an Emerging Model for Translational Research.

Melis N Anahtar, Jason H Yang, Sanjat Kanjilal

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06174519 (Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment), which is not on this map. Cited by 90 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 3 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06174519 completednot on this mapstarted 2023, after this paper: background citation

Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment

TypeobservationalSponsorPragmatech AI SolutionsRan2023 to 2023Enrolled325ConditionsBacterial InfectionsArmsMedical device simulation
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 3 syntheses or guidelines pooled it, 191 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Recent Advances in AI and GenAI for Health Informatics.Healthcare (Basel, Switzerland) · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Observational
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Melis N AnahtarDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jason H YangCenter for Emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.
Sanjat KanjilalDepartment of Population Medicine, Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, Massachusetts, USA.
Brigham and Women's Hospital · USMassachusetts General Hospital · USRutgers, The State University of New Jersey · US

Funding

Genetic, Metabolic and Regulatory Control of MIC and Relapse in M. tuberculosisR01AI146194 · NIAID · UNIVERSITY OF WASHINGTON · PI ALLAND, DAVID, SHERMAN, DAVID R · 2020 to 2024
$4.1M
Effects of Host Metabolic Variation on Antibiotic SusceptibilityR00GM118907 · NIGMS · RBHS-NEW JERSEY MEDICAL SCHOOL · PI YANG, JASON HUNG-YING · 2020 to 2022
$747k
NIAID NIH HHS R01 AI146194NIGMS NIH HHS R00 GM118907
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) remains one of the most challenging phenomena of modern medicine. Machine learning (ML) is a subfield of artificial intelligence that focuses on the development of algorithms that learn how to accurately predict outcome variables using large sets of predictor variables that are typically not hand selected and are minimally curated. Models are parameterized using a training data set and then applied to a test data set on which predictive performance is evaluated. The application of ML algorithms to the problem of AMR has garnered increasing interest in the past 5 years due to the exponential growth of experimental and clinical data, heavy investment in computational capacity, improvements in algorithm performance, and increasing urgency for innovative approaches to reducing the burden of disease. Here, we review the current state of research at the intersection of ML and AMR with an emphasis on three domains of work. The first is the prediction of AMR using genomic data. The second is the use of ML to gain insight into the cellular functions disrupted by antibiotics, which forms the basis for understanding mechanisms of action and developing novel anti-infectives. The third focuses on the application of ML for antimicrobial stewardship using data extracted from the electronic health record. Although the use of ML for understanding, diagnosing, treating, and preventing AMR is still in its infancy, the continued growth of data and interest ensures it will become an important tool for future translational research programs.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsArtificial IntelligenceDrug Resistance, BacterialHumansMachine LearningTranslational Research, BiomedicalAnti-Bacterial AgentsAnti-Infective Agentsantibiotic resistanceantimicrobial stewardshipdrug discoverymachine learningmechanisms of actionwhole-genome sequencing

Identifiers

PMID33536291
PMCPMC8218744
OpenAlexW3127516550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.